Table 4 Demographic and laboratory characteristics of patients according to RRT allocation and ApoE ε4 allele presence

Age (years)

52.47 ± 14.97

53.60 ± 14.36

0.669^*

62.80 ± 13.36

63.81 ± 11.72

0.511^*

Dialysis vintage

38.95 ± 24.24

37.22 ± 27.69

0.697^*

-

-

Male

25 (21.6 %)

91 (78.4 %)

0.574^**

37 (19.7 %)

151 (80.3 %)

0.508^**

Caucasian

31 (22.8 %)

105 (72.2 %)

0.403^**

51 (20.6 %)

196 (79.4 %)

0.440^**

BMI (kg/cm²)

25.15 ± 11.12

25.57 ± 2.44

0.356^*

29.17 ± 6.40

29.33 ± 5.61

0.844^*

Waist circumference (cm)

97.25 ± 15.96

99.30 ± 9.13

0.283^*

99.81 ± 14.73

100.27 ± 13.59

0.798^*

Diabetes mellitus

15 (23.1 %)

50 (76.9 %)

0.418^**

32 (18.8 %)

138 (81.2 %)

0.895^**

Metabolic syndrome

28 (19.4 %)

116 (80.6 %)

0.621^**

48 (17.8 %)

222 (82.2 %)

0.733^**

Cardiovascular disease

19 (22.6 %)

65 (77.4 %)

0.547^**

26 (19.8 %)

105 (80.2 %)

0.653^**

o Cerebrovascular disease

0 (0.0 %)

20 (100.0 %)

0.016^**

13 (28.3 %)

33 (71.7 %)

0.073^**

o Coronary disease

13 (29.5 %)

31 (70.5 %)

0.096^**

11 (16.9 %)

54 (83.1 %)

0.703^**

o Peripheral vascular disease

9 (20.5 %)

35 (79.5 %)

0.976^**

10 (20.4 %)

39 (76.9 %)

0.697^**

o Congestive Heart Failure

6 (19.4 %)

25 (80.6 %)

0.850^**

7 (14.9 %)

40 (85.1 %)

0.480^**

Statin use

23 (21.9 %)

82 (78.1 %)

0.551^**

38 (19.4 %)

158 (80.6 %)

0.602^**

Cholesterol(mmol/L)

3.75 ± 1.01

3.62 ± 0.90

0.470^*

4.58 ± 1.06

4.75 ± 1.06

0.175^*

HDL-C(mmol/L)

0.97 ± 0.34

1.08 ± 0.46

0.108^*

1.15 ± 0.31

1.22 ± 0.35

0.128^*

LDL-C(mmol/L)

1.92 ± 0.74

1.82 ± 0.76

0.469^*

2.62 ± 0.85

2.79 ± 0.92

0.151^*

Triglycerides(mmol/L)

1.98 ± 1.36

1.66 ± 1.14

0.160^*

1.84 ± 1.06

1.69 ± 0.90

0.237^*

ADMA (uM)

0.95 ± 0.45

1.44 ± 0.96

0.000^*

0.58 ± 0.17

0.63 ± 0.28

0.134^*

CRP (mg/dL)

1.67 ± 3.52

1.42 ± 3.88

0.711^*

0.50 ± 0.72

0.57 ± 0.76

0.468^*